"Slade & Baker Vision is a comprehensive eye care center located in Houston, Texas. Led by the caring and compassionate hands of Dr. Stephen Slade and Dr. Richard Baker, we offer LASIK surgery, cataract surgery, dry eye treatments, glaucoma treatments, near vision solutions, and more. Our mission is to provide the highest quality ophthalmic services in a setting that is inviting to patients of all ethnic and educational backgrounds, that is cost-effective, and exceeds the needs of our community."

During the past decade, Slade & Baker Vision conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Slade & Baker Vision" #1 sponsor was "Topcon Medical Systems, Inc." with 3 trials, followed by "Carl Zeiss Meditec, Inc." with 2 trials sponsored, "Glaukos Corporation" with 2 trials sponsored, "RxSight, Inc." with 2 trials sponsored and "Aldeyra Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Slade & Baker Vision" #1 collaborator was "Abbott Medical Optics" with 1 trials as a collaborator, "ClinReg Consulting Services, Inc." with 1 trials as a collaborator, "Science in Vision" with 1 trials as a collaborator and "Sierra Clinical Services, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Slade & Baker Vision" are "Cataract" (4 trials), "Aphakia" (2 trials), "Corneal Ectasia" (2 trials), "Keratoconus" (2 trials) and "Allergic Conjunctivitis" (1 trials). Many other conditions were trialed in "Slade & Baker Vision" in a lesser frequency.

Most popular intervention types in "Slade & Baker Vision" are "Device" (13 trials), "Drug" (6 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Riboflavin" (3 trials), "Control IOL" (2 trials), "Light Adjustable lens (LAL) and Light Delivery Device (LDD)" (2 trials), "VEGA UV-A Illumination System" (2 trials) and "Biometry" (1 trials). Other intervention names were less common.

The vast majority of trials in "Slade & Baker Vision" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Slade & Baker Vision". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Slade & Baker Vision, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Slade & Baker Vision, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".